Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.
about
The complement system and adverse pregnancy outcomesImmunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy.Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.Meningococcal disease and the complement system.Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and CarriageSerum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood.Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies.Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.Novel Mutations Causing C5 Deficiency in Three North-African Families.Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.
P2860
Q26863600-D1CE518E-9148-47BB-BE86-9EE881662FCBQ33397450-92B54D0D-2315-4F73-BF04-CF06F6D60B9BQ33436512-BB446841-AB21-4AFE-B0E7-4F61AEAECFA4Q34376170-4ECF76AD-99AE-4D0A-9C2D-A046313490BFQ35069163-C91DA540-306F-4AE1-BF7D-84DEBC8D1DE0Q35865898-6D471FBC-61FD-48F2-B70B-7014C64D9922Q37094977-A38650C6-0902-478F-BE91-FA3EF8C64F19Q37531323-C10B4F0E-C24D-46E9-B9C5-C6A877040645Q38563385-85E7E949-9D07-45B1-A612-24B633FD17DDQ40245353-F466F5EF-C15C-4803-96A7-9FC68D4133D4Q40268126-F9CF327E-651E-4715-88BE-782236C890A2Q40357752-CEDAB5A4-9446-45B5-AD1C-DC212A434631Q40736568-EF44E860-BDD4-41ED-B41B-A828D8B2D8F9Q45004244-30ED5E44-A8BE-431A-9640-B9CF46BB986E
P2860
Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Critical roles of complement a ...... mplement genetic deficiencies.
@ast
Critical roles of complement a ...... mplement genetic deficiencies.
@en
type
label
Critical roles of complement a ...... mplement genetic deficiencies.
@ast
Critical roles of complement a ...... mplement genetic deficiencies.
@en
prefLabel
Critical roles of complement a ...... mplement genetic deficiencies.
@ast
Critical roles of complement a ...... mplement genetic deficiencies.
@en
P2093
P2860
P50
P356
P1476
Critical roles of complement a ...... mplement genetic deficiencies.
@en
P2093
Anne-Marie Siebke Trøseid
Audun Aase
Bernt Christian Hellerud
E Arne Høiby
Knut Tore Lappegård
Lisa Høyem Kristiansen
Lisbeth Meyer Naess
Tove Karin Herstad
P2860
P304
P356
10.1128/IAI.01044-09
P407
P577
2009-11-23T00:00:00Z